Minnesota-based St. Jude Medical (NYSE: STJ) announced Wednesday that the Food & Drug Administration has approved a new pericardial aortic stented tissue valve -- the Trifecta. In a statement ...

Device maker St. Jude Medical Inc. has received European approval to begin selling its Trifecta valve, which is designed to replace a patient’s damaged aortic valve. The Trifecta gets its name ...

--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced the European CE Mark approval for the 27mm and 29mm Portico™ Transcatheter Aortic Valve ...

St. Jude Medical, Inc. announces CE Mark approval for its 23 mm Portico Transcatheter Aortic Heart Valve and Transfemoral Delivery System for patients with severe aortic stenosis.

St. Jude said. "The promise of the Trifecta tissue valve to potentially deliver superior hemodynamic performance to currently available stented or stentless aortic valves is very exciting," said ...

--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) , a global medical device company, today announced the first patient implant of its 23 mm Portico™ Transcatheter Aortic Heart Valve using ...

“will help us provide the best care possible for our patients in need of aortic valve replacement and especially those with challenging clinical cases.” The new Trifecta GT valve builds on St. Jude ...

Medical device manufacturer, St. Jude Medical, Inc.STJ recently announced the receipt of CE Mark approval for its 27mm and 29mm Portico Transcatheter Aortic Valve Replacement (TAVR) Systems.

DEAR DR. ROACH: I had a St. Jude's aortic valve put in in 1998. I have taken Coumadin since that time. A couple of years ago, my doctors changed the goal for my INR to 2-3. I don't know why.

The Portico device is the only approved transcatheter valve that can ... with diseased or damaged aortic heart valves," said Frank J. Callaghan, president of the St. Jude Medical Cardiovascular ...

ST. PAUL, Minn., St. Jude Medical, Inc., a global medical device company, today announced the first human implant of its Portico(TM) transcatheter aortic heart valve. The procedure was performed by Dr ...

ST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYS: STJ) , a global medical device company, today announced the first patient implant of its 23 mm Portico™ Transcatheter Aortic Heart Valve ...